Serum Matrix Metalloproteinase-7 Is an Independent Prognostic Biomarker in Advanced Bladder Cancer

Clinical and Translational Medicine - United Kingdom
doi 10.1186/s40169-014-0031-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR‑320a Is an Independent Prognostic Biomarker for Invasive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Serum IGF-I, IGFBP-3, and Matrix Metalloproteinase-7 Levels and Acquired Chemo-Resistance in Advanced Colorectal Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2009English

Elevated Serum RAS P21 Is an Independent Prognostic Factor in Metastatic Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Bladder Cancer-Associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2009English

Matrix Metalloproteinase Polymorphisms Are Associated With Bladder Cancer Invasiveness

Clinical Cancer Research
Cancer ResearchOncology
2007English

KIF23 Is an Independent Prognostic Biomarker in Glioma, Transcriptionally Regulated by TCF-4

Oncotarget
Oncology
2016English

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer

Frontiers in Medicine
Medicine
2019English

Reply: Is Serum Matrix Metalloproteinase 9 a Useful Biomarker in Detection of Colorectal Cancer? Considering Pre-Analytical Interference That May Influence Diagnostic Accuracy

British Journal of Cancer
Cancer ResearchOncology
2008English

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy